The deregulation of CDC6 expression had been reported to be involved in many cancers, such as para-small cell lung carcinomas 16, mantle cell lymphomas 17, prostate cancer 18, Nasopharyngeal carcinoma 19 and breast cancer 20. Here, CDC6 is linked to prostate cancer.